Pavlou S N, Veldhuis J D, Lindner J, Souza K H, Urban R J, Rivier J E, Vale W W, Stallard D J
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
J Clin Endocrinol Metab. 1990 May;70(5):1472-8. doi: 10.1210/jcem-70-5-1472.
LHRH antagonists suppress pituitary and gonadal function by competing with endogenous LHRH for binding to gonadotroph receptors. To determine the mechanism of suppression of gonadotropin secretion we studied the effects of a single dose of a LHRH antagonist on the pulsatile activity of serum bioactive LH (Bio-LH), immunoreactive LH (IR-LH), alpha-subunit, and testosterone for 24 h in normal men. The LHRH antagonist, Nal-Glu [( Ac-D2Nal1,D4ClPhe2,D3Pal3,Arg5,DGlu6-(AA), DAla10]LHRH) was given as a single sc injection of 5 mg to five normal men. Blood samples were collected every 10 min during a 10-h baseline period and for 14 h after administration of the antagonist. IR-LH, alpha-subunit, and testosterone were measured in triplicate, and Bio-LH in duplicate. Pulses were then evaluated using Cluster analysis; all replicates were entered in the pulse analysis. After administration of the Nal-Glu antagonist, IR-LH levels decreased (P less than 0.001) from 2.81 +/- 0.06 at baseline to a nadir of 0.75 +/- 0.02 U/L. Bio-LH levels followed the same pattern, decreasing by 89% (P less than 0.001) from 4.54 +/- 0.13 to a nadir of 0.51 +/- 0.13 U/L 6.8 h after the injection of Nal-Glu. In contrast, serum alpha-subunit levels did not change (P greater than 0.05) during the 14-h period after antagonist administration (0.85 +/- 0.01 and 0.75 +/- 0.01 microgram/L before and after Nal-Glu, respectively). Serum testosterone levels decreased by more than 80%, from 17.6 +/- 0.2 at baseline to a mean nadir of 3.3 +/- 0.7 nmol/L 12.8 h after Nal-Glu administration. Pulse frequency and the number of significant pulses remained the same for all of the measured hormones during the 10-h baseline period and the 14 h after Nal-Glu administration. In contrast, the pulse amplitude of IR-LH, Bio-LH, and testosterone decreased significantly after injection of the antagonist. The pulse amplitude of the alpha-subunit also declined, albeit not significantly. Coincidence analysis revealed that during both the 10-h baseline and the 14-h post-Nal-Glu period there was a highly significant (P less than 10(-5) nonrandom synchrony between peaks of IR-LH, Bio-LH, alpha-subunit, and testosterone. These results suggest that coordinate pulsatile secretion of IR-LH, Bio-LH, and testosterone persists after the administration of 5 mg Nal-Glu LHRH antagonist.(ABSTRACT TRUNCATED AT 400 WORDS)
促性腺激素释放激素(LHRH)拮抗剂通过与内源性LHRH竞争结合促性腺激素细胞受体来抑制垂体和性腺功能。为了确定促性腺激素分泌受抑制的机制,我们研究了单剂量LHRH拮抗剂对正常男性血清生物活性促黄体生成素(Bio-LH)、免疫反应性促黄体生成素(IR-LH)、α亚基和睾酮的脉冲活性的影响,持续24小时。将LHRH拮抗剂Nal-Glu [(Ac-D2Nal1,D4ClPhe2,D3Pal3,Arg5,DGlu6-(AA),DAla10]LHRH以5毫克的剂量单次皮下注射给5名正常男性。在10小时的基线期内每10分钟采集一次血样,并在给予拮抗剂后14小时内采集血样。IR-LH、α亚基和睾酮进行三次重复测量,Bio-LH进行两次重复测量。然后使用聚类分析评估脉冲;所有重复测量值都纳入脉冲分析。给予Nal-Glu拮抗剂后,IR-LH水平从基线时的2.81±0.06降至最低点0.75±0.02 U/L(P<0.001)。Bio-LH水平呈现相同模式,在注射Nal-Glu后6.8小时从4.54±0.13降至最低点0.51±0.13 U/L,下降了89%(P<0.001)。相比之下,在给予拮抗剂后的14小时内,血清α亚基水平没有变化(P>0.05)(Nal-Glu给药前后分别为0.85±0.01和0.75±0.01微克/升)。血清睾酮水平下降超过80%,从基线时的17.6±0.2降至Nal-Glu给药后12.8小时的平均最低点3.3±0.7纳摩尔/升。在10小时的基线期和Nal-Glu给药后的14小时内,所有测量激素的脉冲频率和显著脉冲数保持不变。相比之下,注射拮抗剂后IR-LH、Bio-LH和睾酮的脉冲幅度显著下降。α亚基的脉冲幅度也有所下降,尽管不显著。一致性分析显示,在10小时的基线期和Nal-Glu给药后的14小时内,IR-LH、Bio-LH、α亚基和睾酮的峰值之间存在高度显著的(P<10^(-5))非随机同步性。这些结果表明,给予5毫克Nal-Glu LHRH拮抗剂后,IR-LH、Bio-LH和睾酮的协同脉冲分泌持续存在。(摘要截断于400字)